Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE.

about

M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdA.

P2860

Q41927879-034825F8-8586-4A9E-88BE-AAA4DF653EB5

P2860

Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE.

Item

http://www.wikidata.org/entity/Q40978625

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Deep sequencing analysis of HI ...... e III studies ECHO and THRIVE.

@en

type

Item

label

Deep sequencing analysis of HI ...... e III studies ECHO and THRIVE.

@en

prefLabel

Deep sequencing analysis of HI ...... e III studies ECHO and THRIVE.

@en

P1476

Deep sequencing analysis of HI ...... e III studies ECHO and THRIVE.

@en

P2093

Carl Van Hove

http://www.w3.org/2001/XMLSchema#string

Gaston Picchio

http://www.w3.org/2001/XMLSchema#string

Jeroen Aerssens

http://www.w3.org/2001/XMLSchema#string

Johan Vingerhoets

http://www.w3.org/2001/XMLSchema#string

Kim Thys

http://www.w3.org/2001/XMLSchema#string

Laurence T Rimsky

http://www.w3.org/2001/XMLSchema#string

Sandra De Meyer

http://www.w3.org/2001/XMLSchema#string

Veerle Van Eygen

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects

Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission.

Ultrasensitive detection of minor drug-resistant variants for HIV after nevirapine exposure using allele-specific PCR: clinical significance.

Sequence-specific error profile of Illumina sequencers.

Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations

Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.

Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

P304

798-806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.24395

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26412111

http://www.w3.org/2001/XMLSchema#string

Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE.

about

P2860

P2860

Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698